
Evofem Biosciences, Inc.
OTC:EVFM
0.07 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||
Current Assets: | |||||||||||||
Cash & Cash Equivalents
| 0 | 0 | 2.769 | 7.732 | 71.451 | 15.875 | 1.33 | 1.211 | 11.478 | 37.749 | 75.948 | 4.364 | 11.1 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 8.233 | 0.431 | 0.49 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 0 | 0 | 2.769 | 7.732 | 71.451 | 24.108 | 1.761 | 1.701 | 11.478 | 37.749 | 75.948 | 4.364 | 11.1 |
Net Receivables
| 9.832 | 5.738 | 1.126 | 6.449 | 1.317 | 0.686 | 0.316 | 0.313 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 1.577 | 1.697 | 5.379 | 7.674 | 7.162 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 2.2 | 1.775 | 3.425 | 8.285 | 17.8 | 1.627 | 0.401 | 0.34 | 1.03 | 1.977 | 0.926 | 0.142 | 1.485 |
Total Current Assets
| 13.609 | 9.21 | 12.699 | 30.14 | 97.73 | 26.421 | 2.478 | 2.354 | 12.507 | 39.726 | 76.873 | 4.506 | 12.585 |
Non-Current Assets: | |||||||||||||
Property, Plant & Equipment, Net
| 0.547 | 1.309 | 8.346 | 11.169 | 11.19 | 0.554 | 0.593 | 0.848 | 0.109 | 0.186 | 0.025 | 0.024 | 0.197 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 9.597 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 9.597 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0.8 | 0.25 | 0.5 | 0.75 | 0.2 | 0.2 | 0 | 0 | 0.04 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0.036 | 0.035 | 4.118 | 1.203 | 0.248 | 1.07 | 0.439 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Assets
| 10.18 | 1.344 | 12.464 | 12.372 | 12.238 | 1.874 | 1.532 | 1.598 | 0.309 | 0.386 | 0.025 | 0.024 | 0.237 |
Total Assets
| 23.789 | 10.554 | 25.163 | 42.512 | 109.968 | 28.295 | 4.01 | 3.952 | 12.817 | 40.112 | 76.898 | 4.53 | 12.822 |
Liabilities & Equity: | |||||||||||||
Current Liabilities: | |||||||||||||
Account Payables
| 16.172 | 17.02 | 14.984 | 10.316 | 10.641 | 6.008 | 8.882 | 8.999 | 0 | 4.017 | 0.997 | 0.644 | 0.7 |
Short Term Debt
| 45.96 | 43.365 | 67.995 | 111.258 | 54.699 | 0.197 | 4.01 | 0 | 0 | 2.756 | 0 | 0.207 | 0.628 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 18.316 | 12.078 | 10.851 | 16.089 | 11.943 | 6.454 | 14.437 | 94.348 | 0.902 | 2.326 | 0.912 | 0.678 | 0.58 |
Total Current Liabilities
| 80.448 | 72.463 | 93.83 | 137.663 | 77.283 | 12.659 | 27.329 | 103.347 | 0.902 | 9.1 | 1.91 | 1.528 | 1.909 |
Non-Current Liabilities: | |||||||||||||
Long Term Debt
| 0.007 | 0.008 | 3.133 | 4.424 | 31.241 | 0 | 0 | 0 | 0 | 7.205 | 9.741 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 14.591 | 4.593 | 0 | 0 | 0.097 | 0 | 0.037 | 0.28 | 0 | 0 | 0 | 2.205 | 1.617 |
Total Non-Current Liabilities
| 14.598 | 4.601 | 3.133 | 4.424 | 31.338 | 0 | 0.037 | 0.28 | 0 | 7.205 | 9.741 | 2.205 | 1.617 |
Total Liabilities
| 95.046 | 77.064 | 96.963 | 142.087 | 108.621 | 12.659 | 27.366 | 103.627 | 0.902 | 16.305 | 11.651 | 3.733 | 3.526 |
Equity: | |||||||||||||
Preferred Stock
| 0 | 0 | 0 | 4.74 | 0 | 0 | 0 | 189.871 | 0 | 0 | 0 | 57.489 | 51.052 |
Common Stock
| 0.011 | 0.002 | 0 | 0.016 | 0.008 | 0.005 | 0.003 | 0 | 0.001 | 0.001 | 0.001 | 0 | 0 |
Retained Earnings
| -897.664 | -888.699 | -938.694 | -860.68 | -655.488 | -513.179 | -433.146 | -307.277 | -125.85 | -112.832 | -69.675 | -58.855 | -43.839 |
Accumulated Other Comprehensive Income/Loss
| -2.63 | -0.849 | 49.527 | 5.089 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 829.026 | 823.036 | 817.367 | 751.26 | 656.827 | 528.81 | 409.787 | 17.731 | 137.763 | 136.638 | 134.921 | 2.164 | 2.084 |
Total Shareholders Equity
| -71.257 | -66.51 | -71.8 | -99.575 | 1.347 | 15.636 | -23.356 | -99.675 | 11.915 | 23.807 | 65.247 | 0.797 | 9.296 |
Total Equity
| -71.257 | -66.51 | -71.8 | -99.575 | 1.347 | 15.636 | -23.356 | -99.675 | 11.915 | 23.807 | 65.247 | 0.797 | 9.296 |
Total Liabilities & Shareholders Equity
| 23.789 | 10.554 | 25.163 | 42.512 | 109.968 | 28.295 | 4.01 | 3.952 | 12.817 | 40.112 | 76.898 | 4.53 | 12.822 |